US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist

1.695
+0.065+3.99%

Trading Nov 29 12:33 ET

144.12MMarket Cap-926P/E (TTM)

Century Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Century Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 633.330K	--
--	2024/Q4	-- / 975.000K	--
--	2024/Q3	791.000K / 550.000K	--
--	2024/Q2	771.000K / 666.670K	--
--	2024/Q1	855.000K / 225.000K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 633.330K--

--2024/Q4-- / 975.000K--

--2024/Q3791.000K / 550.000K--

--2024/Q2771.000K / 666.670K--

--2024/Q1855.000K / 225.000K--

Unlock Free Earnings Estimates

Open Account

Century Therapeutics Earnings Reports

Century Therapeutics | 8-K: Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 5 09:11 ET

Century Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5 09:11 ET

Century Therapeutics | 8-K: Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

Aug 8 07:39 ET

Century Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 07:34 ET

Analyst Rating

Updated: Nov 8, 2024

Strong Buy

Buy
75.00%
Hold
25.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall